PTSD & TBI Research News
Although not intended to be a complete compendium of every new story published, this page will present curated articles of importance in PTSD & TBI research. This page will include Chronic Traumatic Encephalopathy (CTE) and Concussions under the retitled "TBI & CTE News" heading.
The links below will take you to articles from previous months.
Check out this great story from CBS 60 Minutes: Mancini's Story
Brian Mancini was an Army First Sergeant who made what was called a "nearly miraculous recovery" from the impact of a roadside IED in Iraq. In retirement, he went on to create Honor House in Phoenix, AZ, whose mission is to provide a complete transitional package that utilizes resources from the community to meet therapeutic needs of our Veterans affected by combat.
Sadly, Brian slipped into psychosis from his TBI & PTSD and died by suicide in 2017.
Click on image to see video report
Check out this important story from CBS 60 Minutes:
Phones, Tablets, and Their Impact on Kids' Brains 📅
60 Minutes has been asking: What impact do mobile devices have on the brain? The most recent report goes inside a groundbreaking study of young minds.
Our questions about the impact of screen time on kids' brains coincided last spring with the beginning of the largest government study ever attempted of adolescent brain development. The Adolescent Brain Cognitive Development (ABCD) study will follow more than 10,000 kids.
Check out this great story from CBS 60 Minutes: SGB for PTSD
Could a simple shot in the neck be a break-through for the debilitating symptoms of post-traumatic stress disorder? The toll from PTSD is growing. About 20 veterans a day commit suicide in what the VA is now calling an epidemic. Only 40% find relief from PTSD with current treatments. The new procedure called stellate ganglion block, or SGB, is so fast-acting that many believe it could be a game changer. Used for decades to treat chronic pain, it's only recently been tried for PTSD. Now the U.S. Army is spending $2 million to find out more. Nobody is calling it a cure, but the promise of a new therapy can't come soon enough for many veterans we spoke with - frustrated and despairing that nothing they have tried has worked.